LDL-C

LDL Cholesterol

Q: What is the difference between LDL and "small dense" LDL?

Standard LDL-C measures the total cholesterol content carried by LDL particles. However, LDL particles vary in size—some are large and buoyant while others are small and dense. Small, dense LDL particles are considered more atherogenic because they penetrate the arterial wall more easily and are more susceptible to oxidation. Advanced lipid testing (LDL particle number or NMR spectroscopy) can measure particle size and count, providing additional risk information beyond standard LDL-C.

Q: How much can diet alone lower LDL cholesterol?

A dedicated heart-healthy diet can typically lower LDL-C by 10–25%. The most effective dietary strategies include reducing saturated fat to less than 7% of calories (can lower LDL by 8–10%), adding 2 grams of plant stanols/sterols daily (6–15% reduction), increasing soluble fiber to 10–25 grams daily (5–10% reduction), and losing 10 pounds if overweight (5–8% reduction). The portfolio diet combining all these approaches has shown reductions of up to 30% in some studies.

Q: Are statins the only medication for high LDL?

No, several medication classes can lower LDL-C. Statins remain first-line therapy (30–50% reduction). Ezetimibe blocks cholesterol absorption in the intestine (additional 15–20% reduction). PCSK9 inhibitors (evolocumab, alirocumab) are injectable medications that can reduce LDL-C by 50–60%. Bempedoic acid works in the liver upstream of statins (15–18% reduction). Inclisiran is a newer twice-yearly injection targeting PCSK9 synthesis. Bile acid sequestrants and niacin are older options used less commonly today.

Lipid Panel

What is LDL Cholesterol?

Low-density lipoprotein cholesterol (LDL-C) is often referred to as "bad" cholesterol because elevated levels are directly linked to the development of atherosclerosis—the buildup of fatty plaques in artery walls. LDL particles carry cholesterol from the liver to the tissues and arteries. When there is too much LDL in the blood, it can penetrate the arterial wall, become oxidized, and trigger an inflammatory response that leads to plaque formation. Over time, these plaques narrow and stiffen the arteries, restricting blood flow and increasing the risk of heart attack and stroke.

LDL cholesterol is the primary target of lipid-lowering therapy and is considered the most important lipid measurement for assessing cardiovascular risk. Unlike total cholesterol, which combines all types, LDL-C specifically measures the cholesterol carried by atherogenic particles. In most standard lipid panels, LDL-C is calculated using the Friedewald equation rather than measured directly, though direct LDL measurement is available when triglycerides are very high. Advances in cardiovascular research have established clear thresholds for LDL-C based on individual risk profiles.

Why It Matters

LDL cholesterol is the single most important modifiable risk factor for atherosclerotic cardiovascular disease (ASCVD). Decades of research, including genetic studies and randomized trials, have confirmed that lower LDL-C levels translate directly to lower rates of heart attack, stroke, and cardiovascular death. For every 39 mg/dL reduction in LDL-C, the risk of major cardiovascular events decreases by approximately 22%. This is why LDL-C is the primary therapeutic target in cardiovascular prevention guidelines worldwide.

Normal Reference Ranges

Group	Range	Unit
Optimal	<100	mg/dL
Near Optimal	100–129	mg/dL
Borderline High	130–159	mg/dL
High	160–189	mg/dL
Very High	≥190	mg/dL
Very High Risk Patients	<70 (goal)	mg/dL

Reference ranges may vary by laboratory. Always compare results to the ranges provided by your testing facility.

What High LDL-C Levels Mean

Common Causes

Familial hypercholesterolemia (genetic)
Diet high in saturated and trans fats
Obesity and sedentary lifestyle
Type 2 diabetes and metabolic syndrome
Hypothyroidism
Nephrotic syndrome
Certain medications (thiazide diuretics, cyclosporine)
Cholestatic liver disease

Possible Symptoms

Typically asymptomatic until atherosclerosis is advanced
Chest pain or angina
Xanthomas (especially with familial hypercholesterolemia)
Premature arcus corneae in younger individuals
Symptoms of heart attack or stroke in severe cases

What to do: Treatment depends on overall cardiovascular risk, not just LDL-C level alone. Lifestyle modifications include reducing saturated fat intake to <7% of calories, increasing soluble fiber (oats, beans, psyllium), regular exercise, and weight loss. Statin therapy is the first-line medication and can reduce LDL-C by 30–50%. Ezetimibe can be added for an additional 15–20% reduction. PCSK9 inhibitors are reserved for high-risk patients not achieving goals with statins and ezetimibe. Bempedoic acid is an option for statin-intolerant patients.

What Low LDL-C Levels Mean

Common Causes

Statin or PCSK9 inhibitor therapy (therapeutic)
Hyperthyroidism
Liver disease with impaired lipoprotein synthesis
Malnutrition or malabsorption
Genetic hypobetalipoproteinemia
Critical illness or sepsis

Possible Symptoms

Very low LDL rarely causes symptoms
Some studies suggest possible association with hemorrhagic stroke at extremely low levels, but evidence is mixed
Potential link to anxiety and depression at very low levels, though causation is unestablished

What to do: Low LDL-C achieved through statin therapy is generally beneficial and associated with reduced cardiovascular events. Clinical trials have shown safety even at very low levels (<25 mg/dL). If LDL is unexpectedly low without medication, investigate for hyperthyroidism, liver disease, or malabsorption. Genetic causes (hypobetalipoproteinemia) are usually benign but should be documented.

When Is LDL-C Testing Recommended?

As part of routine lipid panel screening every 4–6 years for adults
Annually or more frequently with known cardiovascular disease
When monitoring statin or other lipid-lowering therapy
If you have diabetes, hypertension, or family history of early heart disease
After major dietary or lifestyle changes to assess impact

Frequently Asked Questions

Standard LDL-C measures the total cholesterol content carried by LDL particles. However, LDL particles vary in size—some are large and buoyant while others are small and dense. Small, dense LDL particles are considered more atherogenic because they penetrate the arterial wall more easily and are more susceptible to oxidation. Advanced lipid testing (LDL particle number or NMR spectroscopy) can measure particle size and count, providing additional risk information beyond standard LDL-C.

A dedicated heart-healthy diet can typically lower LDL-C by 10–25%. The most effective dietary strategies include reducing saturated fat to less than 7% of calories (can lower LDL by 8–10%), adding 2 grams of plant stanols/sterols daily (6–15% reduction), increasing soluble fiber to 10–25 grams daily (5–10% reduction), and losing 10 pounds if overweight (5–8% reduction). The portfolio diet combining all these approaches has shown reductions of up to 30% in some studies.

No, several medication classes can lower LDL-C. Statins remain first-line therapy (30–50% reduction). Ezetimibe blocks cholesterol absorption in the intestine (additional 15–20% reduction). PCSK9 inhibitors (evolocumab, alirocumab) are injectable medications that can reduce LDL-C by 50–60%. Bempedoic acid works in the liver upstream of statins (15–18% reduction). Inclisiran is a newer twice-yearly injection targeting PCSK9 synthesis. Bile acid sequestrants and niacin are older options used less commonly today.

Related Biomarkers

TCTotal Cholesterol HDL-CHDL Cholesterol TGTriglycerides HbA1cHemoglobin A1c GLUGlucose CRPC-Reactive Protein

Want your LDL-C levels analyzed?

Upload your lab results for an instant AI-powered breakdown of all your biomarkers.

Upload Lab Results →

Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Reference ranges may vary between laboratories. Always consult your healthcare provider for interpretation of your specific test results.